|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Stock-based compensation expense | |||||
| Reduction in the carrying amount of operating lease right-of-use assets | |||||
| Fair value mark-to-market on investments | |||||
| Unrealized foreign currency exchange gain, net | |||||
| Allowance/(reversal) for expected credit losses | |||||
| Loss on settlement of convertible notes | |||||
| (Gain)/loss from equity-method investment | |||||
| Fair value changes in contingent consideration | |||||
| Amortization of non-cash interest expense related to convertible notes | |||||
| Deferred income tax benefit | |||||
| Others, net | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other current assets | |||||
| Other current and non-current assets | |||||
| Income taxes payable, net | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Accrued employee costs | |||||
| Accrued expenses and other liabilities | |||||
| Payment of contingent consideration | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Business acquisition (net of cash acquired) | |||||
| Purchases of investments | |||||
| Proceeds from redemption of investments | |||||
| Investment in equity affiliate | |||||
| Net cash used for investing activities | |||||
| Cash flows from financing activities: | |||||
| Principal payments of finance lease liabilities | |||||
| Proceeds from borrowings | |||||
| Repayments of borrowings | |||||
| Payment of contingent consideration | |||||
| Acquisition of treasury stock | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock | |||||
| Payment of debt issuance costs | |||||
| Net cash used for financing activities | |||||
| Effect of exchange rate changes | |||||
| Net increase/(decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at the beginning of the period | |||||
| Cash, cash equivalents and restricted cash at the end of the period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Settlement of portion of convertible notes through issuance of treasury stock | |||||
| Additions to property and equipment not yet paid | |||||
| Assets acquired under finance lease | |||||
Loading...